Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

AIMS: Non-vitamin K oral anticoagulants are safe and effective for stroke prevention in patients with atrial fibrillation (AF). Data on the safety and efficacy of edoxaban in routine care are limited in Europe. We report 1-year outcomes in patients with AF treated with edoxaban in routine care. METH...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J Cardiovasc Pharmacother
Autors principals: de Groot, Joris R, Weiss, Thomas W, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Waltenberger, Johannes, Steffel, Jan, Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Manu, Marius Constantin, Reimitz, Paul-Egbert, De Caterina, Raffaele, Kirchhof, Paulus
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117428/
https://ncbi.nlm.nih.gov/pubmed/32790837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcvp/pvaa079
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars